Table 6 Mass flow rate (× 10−6 kg/s) and distribution rate of the anticancer agent in model A
From: Computational fluid dynamics study of intra-arterial chemotherapy for oral cancer
Artery | Class 1 | Class 2 | Class 3 | Class 4 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
C | LA (F) | LA (L) | LA (R) | LA (B) | C | LA (F) | LA (L) | LA (R) | LA (B) | C | LA (F) | LA (L) | LA (R) | LA (B) | ||
OA (R) | OA (F) | OA (B) | OA (L) | OA (R) | OA (F) | OA (B) | OA (L) | OA (R) | OA (F) | OA (B) | OA (L) | |||||
FA (L) | FA (B) | FA (F) | FA (R) | FA (L) | FA (B) | FA (F) | FA (R) | FA (L) | FA (B) | FA (F) | FA (R) | |||||
ICA | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
SThA | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
LA | 0 (0%) | 9.8 (74.2%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 13.2 (100%) |
OA | 0 (0%) | 0 (0%) | 4.6 (34.8%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 10.4 (78.8%) | 0 (0%) | 0.1 (0.8%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
FA | 9.2 (69.7%) | 3.4 (25.8%) | 0.3 (2.3%) | 13.1 (99.2%) | 10.4 (78.8%) | 6.5 (49.2%) | 13.0 (98.5%) | 0.3 (2.3%) | 12.6 (95.5%) | 12.8 (97.0%) | 10.6 (80.3%) | 12.9 (97.7%) | 0 (0%) | 13.2 (100%) | 7.3 (55.3%) | 0 (0%) |
MA | 4.0 (30.3%) | 0 (0%) | 8.3 (62.9%) | 0.1 (0.8%) | 2.8 (21.2%) | 6.7 (50.8%) | 0.3 (2.3%) | 2.5 (18.9%) | 0.6 (4.5%) | 0.3 (2.3%) | 2.6 (19.7%) | 0.4 (3.0%) | 13.2 (100%) | 0.1 (0.8%) | 5.9 (44.7%) | 0 (0%) |